$2.32 $0.02 (0.9%)

04:00 PM EST on 12/10/19

Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Current Price $2.32 Mkt Cap $38.4M
Open $2.30 P/E Ratio 0.00
Prev. Close $2.30 Div. (Yield) $0.00 (0.0%)
Daily Range $2.27 - $2.35 Volume 93,961
52-Wk Range $2.01 - $11.62 Avg. Daily Vol. 151,341

Caps

How do you think NASDAQ:CLDX will perform against the market?

Add Stock to CAPS Watchlist

All Players

321 Outperform
21 Underperform
 

All-Star Players

53 Outperform
9 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:CLDX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

XMFRendezvous (93.27)
Submitted April 21, 2018

Trading below cash on hand you say? True. Currently has ~130M in cash and cash equivalents on balance sheet vs a MKT cap of about 105M.While I do not know about about the trials that apparently failed here just because it is trading below cash means… More

DigitalDisco (95.13)
Submitted February 11, 2019

reverse split

Recent Community Commentary

Read the most recent pitches from players about CLDX.

Recs

2
Member Avatar DigitalDisco (95.13) Submitted: 2/11/2019 12:36:25 PM : Underperform Start Price: $5.07 NASDAQ:CLDX Score: +69.98

reverse split

Recs

0
Member Avatar oscillation (71.81) Submitted: 6/27/2018 8:19:26 AM : Outperform Start Price: $7.50 NASDAQ:CLDX Score: -84.18

nev

Recs

2
Member Avatar XMFRendezvous (93.27) Submitted: 4/20/2018 10:28:19 PM : Outperform Start Price: $10.56 NASDAQ:CLDX Score: -95.30

Trading below cash on hand you say? True. Currently has ~130M in cash and cash equivalents on balance sheet vs a MKT cap of about 105M.

While I do not know about about the trials that apparently failed here just because it is trading below cash means there is no risk. Company is cash flow negative so unless they shut down their operations (won't) it is likely that the company spends that cash with no guarantee of making a profit.

Will watch closely as more of a case study here.

Leaderboard

Find the members with the highest scoring picks in CLDX.

Score Leader

broman700

broman700 (46.89) Score: +930.88

The Score Leader is the player with the highest score across all their picks in CLDX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hwyman64 < 20 1/23/2009 Underperform 3W $97.80 -97.63% +294.23% +391.86 0 Comment
KidLucifer 92.86 4/13/2009 Underperform NS $107.85 -97.85% +272.93% +370.78 0 Comment
Daxtonwin 99.80 6/2/2009 Underperform 5Y $154.50 -98.50% +233.91% +332.41 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $66.00 -96.48% +183.07% +279.55 0 Comment
etmsmith < 20 6/19/2008 Underperform 3M $214.20 -98.92% +142.68% +241.59 0 Comment
JasonRoth25 55.29 4/10/2008 Underperform 3M $152.25 -98.48% +140.06% +238.54 0 Comment
chtrplyr < 20 6/6/2008 Underperform 5Y $260.25 -99.11% +137.11% +236.21 1 Comment
curtishiggs < 20 5/19/2008 Underperform 3M $224.40 -98.97% +127.59% +226.56 0 Comment
TRSHLog 63.06 3/8/2013 Underperform 3W $177.90 -98.70% +102.27% +200.96 0 Comment
OriginalBarnacle 93.73 3/8/2013 7/1/2013 Underperform 1Y $185.40 -98.75% +101.80% +200.55 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLDX.